Integra LifeSciences Holdings Corporation
IART
$13.57
$0.564.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 273.30M | 273.57M | 277.60M | 296.93M | 677.29M |
| Total Receivables | 252.45M | 272.37M | 256.13M | 277.78M | 248.57M |
| Inventory | 445.42M | 429.09M | 436.93M | 421.78M | 403.42M |
| Prepaid Expenses | 103.87M | 77.00M | 86.33M | 93.64M | 72.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 32.21M | 29.65M | 42.54M | 22.17M | 13.70M |
| Total Current Assets | 1.11B | 1.08B | 1.10B | 1.11B | 1.42B |
|
|
|||||
| Total Current Assets | 1.11B | 1.08B | 1.10B | 1.11B | 1.42B |
| Net Property, Plant & Equipment | 561.38M | 549.77M | 537.25M | 521.04M | 497.19M |
| Long-term Investments | 1.11B | 1.10B | 1.12B | 1.10B | 1.04B |
| Goodwill | 1.11B | 1.10B | 1.12B | 1.10B | 1.04B |
| Total Other Intangibles | 1.19B | 1.21B | 1.21B | 1.22B | 1.02B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.27M | 63.14M | 76.49M | 73.14M | 61.54M |
| Total Assets | 4.05B | 4.04B | 4.07B | 4.07B | 4.08B |
|
|
|||||
| Total Accounts Payable | 91.30M | 82.50M | 77.67M | 107.49M | 94.40M |
| Total Accrued Expenses | 187.59M | 169.74M | 178.06M | 170.95M | 123.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 627.76M | 622.30M | 616.81M | 39.44M | 36.22M |
| Total Finance Division Other Current Liabilities | 11.81M | 47.59M | 40.03M | 10.44M | 47.91M |
| Total Other Current Liabilities | 11.81M | 47.59M | 40.03M | 10.44M | 47.91M |
| Total Current Liabilities | 918.45M | 922.13M | 912.56M | 328.32M | 302.39M |
|
|
|||||
| Total Current Liabilities | 918.45M | 922.13M | 912.56M | 328.32M | 302.39M |
| Long-Term Debt | 1.23B | 1.20B | 1.21B | 1.80B | 1.84B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 161.48M | 166.93M | 167.81M | 169.56M | 170.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 217.09M | 205.93M | 257.07M | 240.02M | 169.59M |
| Total Liabilities | 2.53B | 2.49B | 2.54B | 2.54B | 2.48B |
|
|
|||||
| Common Stock & APIC | 1.32B | 1.32B | 1.32B | 1.30B | 1.31B |
| Retained Earnings | 914.62M | 939.92M | 920.48M | 931.18M | 943.58M |
| Treasury Stock & Other | -714.49M | -718.98M | -716.66M | -699.48M | -657.07M |
| Total Common Equity | 1.52B | 1.55B | 1.52B | 1.53B | 1.60B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.52B | 1.55B | 1.52B | 1.53B | 1.60B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.52B | 1.55B | 1.52B | 1.53B | 1.60B |
|
|
|||||